NASDAQ: KRON
Kronos Bio Inc Stock Ownership - Who owns Kronos Bio?

Insider buying vs selling

Have Kronos Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Norbert W. BischofbergerPRESIDENT CEO2024-06-28204,670$1.25
$255.02kBuy
Norbert W. BischofbergerPRESIDENT CEO2024-06-27410,848$1.17
$478.64kBuy
Norbert W. BischofbergerPRESIDENT CEO2024-06-12881,913$1.24
$1.10MBuy
Norbert W. BischofbergerPRESIDENT CEO2024-06-11744,308$1.09
$814.27kBuy
Norbert W. BischofbergerPRESIDENT CEO2024-06-101,378,901$0.88
$1.21MBuy

1 of 1

KRON insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KRON insiders and whales buy or sell their stock.

KRON Shareholders

What type of owners hold Kronos Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Norbert W. Inger A. Revocable Inter Vivos Trust Bischofberger7.17%4,370,496$3.93MInsider
Omega Fund V LP6.26%3,818,283$3.43MInsider
Otello Stampacchia6.26%3,818,283$3.43MInsider
Norbert W. Bischofberger5.04%3,074,754$2.76MInsider
Arie Belldegrun4.91%2,994,889$2.69MInsider
Vida Ventures Advisors LLC4.54%2,765,314$2.49MInstitution
John C. Martin3.20%1,952,364$1.76MInsider
Vanguard Group Inc3.15%1,922,809$1.73MInstitution
Millennium Management LLC2.82%1,716,501$1.54MInstitution
Alphabet Inc2.36%1,438,232$1.29MInstitution

1 of 3

KRON vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KRON32.23%42.19%Net Buying
ACET69.68%19.41%Net Selling
MRSN37.43%62.57%Net Selling
OKYO0.19%99.81%
CYCC0.34%97.50%Net SellingNet Selling

Kronos Bio Stock Ownership FAQ

Who owns Kronos Bio?

Kronos Bio (NASDAQ: KRON) is owned by 32.23% institutional shareholders, 42.19% Kronos Bio insiders, and 25.58% retail investors. Norbert W. Inger A. Revocable Inter Vivos Trust Bischofberger is the largest individual Kronos Bio shareholder, owning 4.37M shares representing 7.17% of the company. Norbert W. Inger A. Revocable Inter Vivos Trust Bischofberger's Kronos Bio shares are currently valued at $3.90M.

If you're new to stock investing, here's how to buy Kronos Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.